CardioDx Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Out of Business

  • Employees
  • 156

Employees

  • Latest Deal Type
  • Out of Business

CardioDx General Information

Description

CardioDx Inc was incorporated in Delaware in July 2003. The Company is a molecular diagnostics company developing and commercializing novel, proprietary tests that help improve treatment decisions, enhance patient outcomes and reduce the overall cost of care. It uses genomic technologies to provide healthcare professionals with critical, actionable information to improve patient care and management. It focuses on diagnostics for cardiovascular diseases, such as coronary artery diseases, or CAD, arrhythmia and heart failure. Its Corus CAD test is a blood-based gene expression test that provides a current-state assessment for non-diabetic patients with symptoms that are suggestive of obstructive CAD.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 600 Saginaw Drive
  • Redwood City, CA 94063
  • United States
+1 (650)
Primary Industry
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 600 Saginaw Drive
  • Redwood City, CA 94063
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CardioDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Out of Business 09-Jan-2019 Completed Out of Business
12. Later Stage VC (Series 1) 17-Jan-2017 Completed Generating Revenue
11. Later Stage VC (Series DD) 22-Feb-2016 Completed Generating Revenue
10. Debt - General 01-Sep-2015 Completed Generating Revenue
9. Mezzanine 18-Jun-2015 Completed Generating Revenue
8. IPO 23-Dec-2014 Cancelled Generating Revenue
7. Later Stage VC (Series DD) 18-Dec-2014 Completed Generating Revenue
6. Later Stage VC (Series CC) 27-Aug-2012 Completed Generating Revenue
5. Later Stage VC (Series BB) 11-May-2011 $60M $140M Completed Generating Revenue
4. Later Stage VC (Series D) 13-May-2010 $35M $79.9M Completed Generating Revenue
To view CardioDx’s complete valuation and funding history, request access »

CardioDx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series 1B
Series 1A
To view CardioDx’s complete cap table history, request access »

CardioDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
CardioDx Inc was incorporated in Delaware in July 2003. The Company is a molecular diagnostics company developing and co
Other Devices and Supplies
Redwood City, CA
156 As of 2015

Madison, WI
 

Danvers, MA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CardioDx Competitors (31)

One of CardioDx’s 31 competitors is Accuray, a Formerly VC-backed company based in Madison, WI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Accuray Formerly VC-backed Madison, WI
NeuroLogica Formerly VC-backed Danvers, MA
Avvio Medical Venture Capital-Backed San Francisco, CA
Myriad Genetics Corporation Salt Lake City, UT
NalaGenetics Venture Capital-Backed Singapore, Singapore
You’re viewing 5 of 31 competitors. Get the full list »

CardioDx Patents

CardioDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018160548-A1 Markers for coronary artery disease and uses thereof Inactive 28-Feb-2017
CA-2996191-A1 Markers for coronary artery disease and uses thereof Inactive 01-Sep-2015
EP-3344986-A1 Markers for coronary artery disease and uses thereof Inactive 01-Sep-2015
EP-3344986-A4 Markers for coronary artery disease and uses thereof Inactive 01-Sep-2015
US-20180356432-A1 Markers for coronary artery disease and uses thereof Inactive 01-Sep-2015 G01N33/6893
To view CardioDx’s complete patent history, request access »

CardioDx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CardioDx FAQs

  • When was CardioDx founded?

    CardioDx was founded in 2004.

  • Where is CardioDx headquartered?

    CardioDx is headquartered in Redwood City, CA.

  • What is the size of CardioDx?

    CardioDx has 156 total employees.

  • What industry is CardioDx in?

    CardioDx’s primary industry is Other Devices and Supplies.

  • Is CardioDx a private or public company?

    CardioDx is a Private company.

  • What is CardioDx’s current revenue?

    The current revenue for CardioDx is .

  • How much funding has CardioDx raised over time?

    CardioDx has raised $324M.

  • Who are CardioDx’s competitors?

    Accuray, NeuroLogica, Avvio Medical, Myriad Genetics, and NalaGenetics are some of the 31 competitors of CardioDx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process